HIGHLIGHTS
- who: MDPI from the First University Athens, Athens, Greece have published the research: Type of the Paper (Article, in the Journal: Cancers 2022, 14, 6178. of /2022/
- what: To further emphasize the significance of the Src-YAP signaling axis in the pathobiology of NSCLC, the authors of the review discuss its association with the development of resistance to targeted therapy.
SUMMARY
Accounts for the majority (~85%) of all lung cancer cases. Most of these mutations occur in transmembrane receptors or intracellular protein_kinases and result in the abnormal activation of signal_transduction pathways . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.